Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 5, 2001, Pages 391-397

  Nakamura, K ^a   Kariyazono, H ^a   Masuda, H ^a   Sakata, R ^a   Yamada, K ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adenosine diphosphate; Collagen; Platelet aggregation; Platelet derived growth factor; Sarpogrelate hydrochloride; SP selectin; Transforming growth factor 1

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; SARPOGRELATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS;

ADENOSINE DIPHOSPHATE; AGED; ARTERIOSCLEROSIS OBLITERANS; CASE-CONTROL STUDIES; COLLAGEN; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET-DERIVED GROWTH FACTOR; SEROTONIN ANTAGONISTS; SUCCINATES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0034909126     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200107000-00009     Document Type: Article

References (45)

1. The pathogenesis of arteriosclerosis
2. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: Implications for atherogenesis? A preliminary report
3. Platelet activation and serotonin
4. MCI-9042, a new antiplatelet agent is a selective S2serotonergic receptor antagonist
5. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies
6. Cloning of GMP-140, a granule membrane protein, of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation
7. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
8. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation
9. GMP-140 binds to a glycoprotein receptor on human neutrophils: Evidence for a lectin-like interaction
10. Characterization of GMP-140 (P-selectin) as a circulating plasma protein
11. Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
12. Increased levels of soluble P-selectin in hypercholesterolemic patients
13. Inhibitory effects of H2 receptor antagonists on platelet function in vitro
14. Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin
15. Interleukin-1 mitogenic activity of fibroblasts and smooth muscle cells is due to PDGF-AA
16. Regulation of platelet-derived growth factor ligand and gene expression by α-thrombin in vascular smooth muscle cell
17. Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin
18. The serum concentration of active transforming growth factor beta is severely depressed in advanced atherosclerosis
19. Active macrophage-associated in TGF-beta colocalizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries
20. Syntheses and platelet aggregation inhibitory and antithrombotic properties of [2-[(w-aminoalkoxy) phenyl]ethyl]benzenes
21. The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease
22. Therapeutic effects of sarpogrelate hydrochloride (MCI-9042) on chronic arterial occlusive diseases - A double-blind comparison with ticlopidine hydrochloride
23. Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement
24. Inhibitory effects of antibiotics on platelet aggregation in vitro
25. The pathogenesis of atherosclerosis: A perspective for the 1990s
26. Atherosclerosis plaque rupture and thrombosis; evolving concepts
27. Role of platelet activation and fibrin formation in thrombogenesis
28. Stimulation of aortic smooth muscle cell mitogenesis by serotonin
29. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture
30. Role of selectins in myocardial ischemia-reperfusion injury
31. Adhesion receptors of the immune system
32. Selectins: Novel receptors that mediate leukocyte adhesion during inflammation
33. Selectins: Interpreters of cell-specific carbohydrate information during inflammation
34. Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers
35. Transforming growth factor beta 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion
36. Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner
37. Platelets and foam cell in the evolution of atherosclerosis. Histological and immunohistological studies in human lesions
38. Increased plasma levels of platelet-derived growth factor (PDGF-BB + PDGF-AB) in patients with never-treated mild essential hypertension
39. Circulating transforming growth factor beta 1 and coronary artery disease
40. Active macrophage-associated in TGF-beta colocalizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries
41. Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets
42. Effects of serotonin on platelets and blood vessels
43. Amplification mechanisms in platelet activation
44. Molecular basis for ADP-induced platelet activation
45. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel